Bella Pharmaceuticals Recalls MIC 25/50/50 Vials Due to Sterility Concerns
Bella Pharmaceuticals is recalling MIC 25/50/50 vials because the company cannot ensure the product is sterile. The recall affects 5 vials distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility, which poses a significant risk of serious injury or infection, meeting the criteria for a Severe rating.
Plain-English summary
Bella Pharmaceuticals, Inc. is recalling MIC 25/50/50, 30mL vials, which are prescription-only medications. The recall is being conducted because the company lacks assurance of the product's sterility.
The affected product consists of 5 vials with Lot # BPMIC30072917 and an expiration date of 1/29/18. These vials were distributed nationwide within the United States.
Consumers and healthcare providers should stop using the recalled product and contact Bella Pharmaceuticals at 1 (877) BELLA for further instructions.
The recalled product
- Product
- MIC 25/50/50, 30mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.
- Manufacturer
- Bella Pharmaceuticals, Inc.
- Category
- Drug — Injectable Medication
- Affected units
- 5
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: BPMIC30072917
- Exp. 1/29/18
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Bella Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Bella Pharmaceuticals, Inc.
See all →- SevereBella Pharmaceuticals Recalls Mannitol 20% Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls B-Complex Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls Fluorescein Sodium Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls L-Glutamine Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls PF-Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereMedaus Recalls M.I.C 25/50/50 Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- HighMIC/B12 Injectable Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- SevereMedaus Recalls M.I.C. 25/50/50 Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereWells Pharmacy Recalls MIC/B12 Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereWells Pharmacy Recalls MIC/B-COMP+LIDO Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereWells Pharmacy Recalls MIC/B-Complex Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11